N00.A Acute nephritic syndrome with C3 glomerulonephritis

Name of the Condition

• Acute Nephritic Syndrome with C3 Glomerulonephritis
• ICD-10 Code: N00.A

Summary

Acute nephritic syndrome with C3 glomerulonephritis is a kidney disorder characterized by sudden inflammation of the glomeruli, the kidney's filtering units, due to complement C3 dysregulation. This condition leads to hematuria (blood in urine), proteinuria (excess protein in urine), and reduced kidney function. The term "C3 glomerulonephritis" indicates that the underlying pathology involves abnormal complement activation, distinguishing it from other forms of glomerulonephritis.

Causes

Acute nephritic syndrome with C3 glomerulonephritis is caused by dysregulation of the complement system, particularly involving complement component C3. This can result from genetic mutations, autoantibodies (e.g., C3 nephritic factor), or underlying conditions like infections or autoimmune diseases. The exact trigger may vary, but the common pathway is uncontrolled complement activation leading to glomerular damage.

Risk Factors

• Complement dysregulation: Genetic or acquired abnormalities in the complement system.
• Autoimmune conditions: Diseases such as systemic lupus erythematosus or IgA nephropathy.
• Infections: Recent bacterial or viral infections that may trigger immune responses.
• Family history: Genetic predisposition to complement-related kidney diseases.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (foamy or frothy urine).
• Edema (swelling in the face, hands, or legs).
• Hypertension (high blood pressure).
• Oliguria (reduced urine output).

Diagnosis

Diagnosis involves urinalysis to detect blood and protein, blood tests to assess kidney function and complement levels, and a kidney biopsy to identify C3 deposition and glomerular changes. Imaging studies may be used to evaluate kidney structure, and genetic testing can help identify underlying complement abnormalities.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. This may include medications to control blood pressure and reduce proteinuria (e.g., ACE inhibitors or ARBs), immunosuppressants for autoimmune triggers, and plasma exchange or complement inhibitors in severe cases. Supportive care, such as diuretics for edema, is also common.

Prognosis and Follow-Up

Prognosis varies depending on the severity of kidney damage and response to treatment. Some patients may recover fully, while others may develop chronic kidney disease. Regular follow-up with kidney function tests, blood pressure monitoring, and urine analysis is essential to detect progression or complications early.

Complications

• Chronic kidney disease or kidney failure.
• Hypertension.
• Edema-related complications (e.g., pulmonary edema).
• Increased risk of infections due to immunosuppressive therapy.

Lifestyle & Prevention

• Maintain a low-sodium, kidney-friendly diet to manage blood pressure and edema.
• Stay hydrated, but follow medical advice for fluid intake if kidney function is impaired.
• Avoid medications that may harm the kidneys (e.g., certain NSAIDs) unless prescribed.
• Manage underlying conditions like infections or autoimmune diseases promptly.

When to Seek Professional Help

Seek immediate medical attention if you experience severe symptoms such as sudden swelling, chest pain, shortness of breath, or significantly reduced urine output. Regular check-ups are recommended for those with known risk factors or a history of kidney disease.

Tips for Medical Coders

When coding for acute nephritic syndrome with C3 glomerulonephritis (N00.A), ensure documentation supports the diagnosis, including clinical findings (e.g., hematuria, proteinuria) and confirmation of C3-related pathology (e.g., biopsy results or complement testing). Verify that the code aligns with the specific subtype and exclude codes for other nephritic syndromes unless documented.